Kevin O. Saunders

9.7k total citations · 3 hit papers
58 papers, 1.9k citations indexed

About

Kevin O. Saunders is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Kevin O. Saunders has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Virology, 25 papers in Immunology and 23 papers in Infectious Diseases. Recurrent topics in Kevin O. Saunders's work include HIV Research and Treatment (40 papers), Immune Cell Function and Interaction (15 papers) and vaccines and immunoinformatics approaches (13 papers). Kevin O. Saunders is often cited by papers focused on HIV Research and Treatment (40 papers), Immune Cell Function and Interaction (15 papers) and vaccines and immunoinformatics approaches (13 papers). Kevin O. Saunders collaborates with scholars based in United States, United Kingdom and Canada. Kevin O. Saunders's co-authors include Barton F. Haynes, Kevin Wiehe, Priyamvada Acharya, Bette Korber, Georgia D. Tomaras, Gregory D. Sempowski, Robert Parks, Stephanie A. Freel, Gary J. Nabel and Dapeng Li and has published in prestigious journals such as Science, Cell and Nature Communications.

In The Last Decade

Kevin O. Saunders

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity

2021 247 citations S. Gobeil, Katarzyna Janowska et al. Science profile →
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies

2022 162 citations Barton F. Haynes, Kevin Wiehe et al. Nature reviews. Immunology profile →
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

2021 93 citations David R. Martinez, Alexandra Schäfer et al. Science profile →

Peers

Countries citing papers authored by Kevin O. Saunders

Since Specialization

Citations

This map shows the geographic impact of Kevin O. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin O. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin O. Saunders more than expected).

Fields of papers citing papers by Kevin O. Saunders

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin O. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin O. Saunders. The network helps show where Kevin O. Saunders may publish in the future.

Co-authorship network of co-authors of Kevin O. Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin O. Saunders. A scholar is included among the top collaborators of Kevin O. Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin O. Saunders. Kevin O. Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Acquisition of quaternary trimer interaction as a key step in the lineage maturation of a broad and potent HIV-1 neutralizing antibody 2025 ·Structure ·Qingbo Liu, Ruth Parsons, (unknown), Robert J. Edwards, Kevin O. Saunders, Peng Zhang, Huiyi Miao, Kedamawit Tilahun, (unknown), Yue Chen, Bhavna Hora, Wilton B. Williams, David Easterhoff, Xiao Huang, Katarzyna Janowska, Katayoun Mansouri, Barton F. Haynes, Priyamvada Acharya, Paolo Lusso	0
2	SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition 2024 ·Molecular Cell ·(unknown), Jared Lindenberger, Ruth Parsons, (unknown), Rob Parks, (unknown), (unknown), (unknown), Katarzyna Janowska, (unknown), Robert J. Edwards, Mitchell Martin, Wilton B. Williams, S. Gobeil, David C. Montefiori, Bette Korber, Kevin O. Saunders, Barton F. Haynes, Rory Henderson, Priyamvada Acharya	10
3	Microsecond dynamics control the HIV-1 Envelope conformation 2024 ·Science Advances ·(unknown), Robert J. Edwards, Irina Kosheleva, (unknown), (unknown), (unknown), (unknown), (unknown), Kara Anasti, Kevin O. Saunders, S. Munir Alam, Barton F. Haynes, Priyamvada Acharya, Rory Henderson	6
4	Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies 2023 ·Nature reviews. Immunology ·Barton F. Haynes, Kevin Wiehe, Persephone Borrow, Kevin O. Saunders, Bette Korber, (unknown), Andrew J. McMichael, Garnett Kelsoe, Beatrice H. Hahn, Frederick W. Alt, George M. Shaw	6
5	Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage 2023 ·Nature Communications ·Rory Henderson, Ye Zhou, Victoria Stalls, Kevin Wiehe, Kevin O. Saunders, Kshitij Wagh, Kara Anasti, Maggie Barr, Robert Parks, S. Munir Alam, Bette Korber, Barton F. Haynes, Alberto Bartesaghi, Priyamvada Acharya	7
6	Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies breakdown → 2022 ·Nature reviews. Immunology ·Barton F. Haynes, Kevin Wiehe, Persephone Borrow, Kevin O. Saunders, Bette Korber, Kshitij Wagh, Andrew J. McMichael, Garnett Kelsoe, Beatrice H. Hahn, Frederick W. Alt, George M. Shaw	162
7	Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice breakdown → 2021 ·Science ·David R. Martinez, Alexandra Schäfer, Sarah R. Leist, Gabriela De la Cruz, Ande West, Elena N. Atochina‐Vasserman, Lisa C. Lindesmith, Norbert Pardi, Robert Parks, Maggie Barr, Dapeng Li, Boyd L. Yount, Kevin O. Saunders, Drew Weissman, Barton F. Haynes, Stephanie A. Montgomery, Ralph S. Baric	93
8	Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus 2021 ·The Journal of Infectious Diseases ·(unknown), Youyi Fong, (unknown), Maria Dennis, Joshua Eudailey, Ashley N. Nelson, Kevin O. Saunders, Coleen K. Cunningham, Elizabeth J. McFarland, Ross E. McKinney, M. Anthony Moody, Celia C. LaBranche, David C. Montefiori, Sallie R. Permar, Genevieve G. Fouda	6
9	Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity breakdown → 2021 ·Science ·S. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Victoria Stalls, Megan Kopp, Kartik Manne, Dapeng Li, Kevin Wiehe, Kevin O. Saunders, Robert J. Edwards, Bette Korber, Barton F. Haynes, Rory Henderson, Priyamvada Acharya	247
10	Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates 2021 ·Science Translational Medicine ·Nicole Darricarrère, Yu Qiu, Masaru Kanekiyo, Adrian Creanga, Rebecca A. Gillespie, Syed M. Moin, Jacqueline Saleh, José Sancho, Te-Hui Chou, (unknown), Ruijun Zhang, Shujia Dai, M. Anthony Moody, Kevin O. Saunders, Michelle C. Crank, John R. Mascola, Barney S. Graham, Chih‐Jen Wei, Gary J. Nabel	46
11	Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations 2021 ·Cell Reports ·(unknown), (unknown), (unknown), Shi-Mao Xia, Robert Parks, Haiyan Chen, Aja Sanzone, Melissa Cooper, Mark K. Louder, Bob C. Lin, Nicole A. Doria‐Rose, Mattia Bonsignori, Kevin O. Saunders, Kevin Wiehe, Barton F. Haynes, Mihai L. Azoitei	4
12	Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques 2020 ·npj Vaccines ·Maria Blasi, (unknown), Erich J. Baker, (unknown), Celia C. LaBranche, Wes Rountree, Barton F. Haynes, Kevin O. Saunders, M. Anthony Moody, Donatella Negri, Sampa Santra, Andrea Cara, Mary E. Klotman	14
13	Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19 2020 ·Cell ·Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Kevin Wiehe, Barton F. Haynes	61
14	Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations 2019 ·Nature Communications ·Qi Han, (unknown), Nathan I. Nicely, (unknown), Xiaoying Shen, Katayoun Mansouri, Mark K. Louder, Ashley M. Trama, S. Munir Alam, Robert J. Edwards, Mattia Bonsignori, Georgia D. Tomaras, Bette Korber, David C. Montefiori, John R. Mascola, Michael S. Seaman, Barton F. Haynes, Kevin O. Saunders	20
15	Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life 2019 ·Frontiers in Immunology ·Kevin O. Saunders	204
16	Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation 2018 ·PLoS Pathogens ·Ema T. Crooks, Samantha L. Grimley, Michelle D. Cully, Keiko Osawa, Gillian Dekkers, Kevin O. Saunders, Sebastian Rämisch, Sergey Menis, William R. Schief, Nicole A. Doria‐Rose, Barton F. Haynes, Ben Murrell, Evan M. Cale, Amarendra Pegu, John R. Mascola, Gestur Vidarsson, James Μ. Binley	19
17	Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection 2015 ·Cell ·Xueling Wu, Zhenhai Zhang, Chaim A. Schramm, Michael Joyce, Young Do Kwon, Tongqing Zhou, Zizhang Sheng, Baoshan Zhang, Sijy O’Dell, Krisha McKee, (unknown), Gwo‐Yu Chuang, Nancy S. Longo, Rebecca M. Lynch, Kevin O. Saunders, Cinque Soto, Sanjay Srivatsan, Yongping Yang, Robert T. Bailer, Mark K. Louder, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	150
18	Epigenetic regulation of CD8+ T-lymphocyte mediated suppression of HIV-1 replication 2010 ·Virology ·Kevin O. Saunders, Stephanie A. Freel, R. Glenn Overman, Coleen K. Cunningham, Georgia D. Tomaras	14
19	CD8+T-cell-mediated control of HIV-1 and SIV infection 2010 ·Immunologic Research ·Stephanie A. Freel, Kevin O. Saunders, Georgia D. Tomaras	40
20	tomography scanning in HIV-positive Is there a role for positron emission patients with Kaposi's sarcoma and lymphadenopathy: two case reports 1997 ·International Journal of STD & AIDS ·Ranjababu Kulasegaram, Kevin O. Saunders, C Bradbeer, Michael O’Doherty	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact